Research results have now shown that metformin acts on liver cells to reduce the glucose production in the liver, inhibit liver glycogen decomposition, and improve the insulin sensitivity of glucose metabolism in the muscles, thereby reducing blood sugar in patients with T2DM. Here, INS is linked to type 2 diabetes mellitus.